Medifast
MED • NYSE
Medifast is a personal products & services company in the consumer cyclical sector trading on NYSE, led by CEO Daniel R. Chard, with a market cap of $119.0M.
CEODaniel R. Chard
Market Cap$119.0M
Personal Products & Services
Consumer Cyclical
Employees634.0
Websitemedifastinc.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Medifast
Date
Monday, April 27, 2026 (in 3 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.26
Revenue Estimate
$78.1M
Earnings History
Past 11 earnings reports for Medifast
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 3, 2025 | Q3 2025 | -$0.21Est: -$0.22 | +4.5% | $89.4MEst: $88.2M | +1.4% |  10-Q |
| Aug 4, 2025 | Q2 2025 | $0.22Est: -$0.19 | +215.8% | $105.6MEst: $99.1M | +6.5% | 10-Q |
| Apr 28, 2025 | Q1 2025 | -$0.07Est: -$0.25 | +72.0% | $115.7MEst: $116.4M | -0.6% | 10-Q |
| Feb 18, 2025 | Q4 2024 | $0.10Est: -$0.16 | +162.5% | $119.0MEst: $114.3M | +4.2% | 10-K |
| Nov 4, 2024 | Q3 2024 | $0.35Est: -$0.28 | +225.0% | $140.2MEst: $134.2M | +4.5% | 10-Q |
| Aug 5, 2024 | Q2 2024 | $0.92Est: $0.37 | +148.6% | $168.6MEst: $163.7M | +3.0% | 10-Q |
| Apr 29, 2024 | Q1 2024 | $0.66Est: $0.78 | -15.4% | $174.7MEst: $168.9M | +3.5% | 10-Q |
| Feb 20, 2024 | Q4 2023 | $1.09Est: $0.96 | +13.5% | $191.0MEst: $184.2M | +3.7% | 10-K |
| Nov 6, 2023 | Q3 2023 | $2.12Est: $1.06 | +100.0% | $235.9MEst: $232.1M | +1.6% | — |
| Aug 7, 2023 | Q2 2023 | $2.77Est: $1.44 | +92.4% | $296.2MEst: $253.5M | +16.9% | 10-Q |
| May 1, 2023 | Q1 2023 | $3.67Est: $2.40 | +52.9% | $349.0MEst: $319.5M | +9.2% | 10-Q |